| Calls for inquiry 
                            after cisapride linked to 136 deaths   Jamie Doward, social affairs editorSunday February 1, 2004
 The 
                            Observer
 A drug linked to more than 100 deaths is being blamed 
                            for a series of gross miscarriages of justice that 
                            have seen hundreds of parents wrongly accused of child 
                            abuse. A conference drawing together psychologists, social 
                            workers and scientists will hear evidence this week 
                            that a drug called cisapride - used to treat digestive 
                            problems and now withdrawn from the UK market - has 
                            resulted in hundreds of cases of wrong diagnosis. 
                           Experts will claim the drug is known to interrupt 
                            the rhythm of the heart, causing some youngsters to 
                            turn pale and experience breathing difficulties. Campaigners 
                            say the symptoms have prompted doctors to wrongly 
                            accuse parents of trying to smother their children. 
                           The revelation will raise further questions about 
                            the validity of the controversial condition Munchausen 
                            Syndrome by Proxy (MSBP) - first theorised in 1977 
                            by paediatrician Professor Sir Roy Meadow - which 
                            suggests some parents harm their children to draw 
                            attention to themselves.  Critics of MSBP, which has been discredited following 
                            a series of court cases, fear it blinds social workers, 
                            lawyers and judges to other explanations for apparent 
                            child abuse, such as the side effects of drugs or 
                            the symptons associated with a number of illnesses. 
                           The conference, at Sydney University in Australia, 
                            aims to debunk MSBPand is set to attract worldwide 
                            attention. It will hear calls for a full investigation 
                            into cisapride, which was withdrawn in the US and 
                            the UK three years ago after it was linked to 136 
                            deaths worldwide, including those of two British children. 
                           'Given the amount of cases where cisapride has played 
                            a significant part in the child's treatment and the 
                            child's parents have been diagnosed as having MSBP, 
                            it is imperative the Government launches an investigation 
                            into this drug,' said Penny Mellor an anti-MSBP campaigner. 
                           The Government said last month that it is to investigate 
                            more than 250 criminal cases in which a parent had 
                            been convicted of murdering a child. The decision 
                            was taken after a series of overturned convictions. 
                           Sally Clark was freed after spending three years 
                            in jail for killing her two children. Trupti Patel 
                            was acquitted of smothering her three babies. Angela 
                            Cannings, jailed for killing her two sons, was released 
                            by the Court of Appeal last December.  The Government is also planning to ask local authorities 
                            to examine up to 5,000 cases in which children were 
                            taken from their parents in the civil courts and in 
                            which MSBP may have been cited. Authorities in the 
                            US, Canada, Australia and New Zealand, are also under 
                            pressure to examine cases in which parents were separated 
                            from their children following the diagnosis of MSBP. 
                           The first civil cases involving parents who claim 
                            they were wrongly separated from their children as 
                            a result of MSBP, are currently being prepared for 
                            appeal.  Meadow and another paediatrician who has advanced 
                            the MSBP theory, Professor David Southall, are now 
                            the subjects of separate inquiries by the General 
                            Medical Council. The Observer has also learnt that 
                            there are at least four other experts in the field 
                            of MSBP whose work is now likely to be scrutinised 
                            by the health authorities.  Since The Observer highlighted the allegation that 
                            MSBP was responsible for a series of miscarriages 
                            of justice last week, numerous other cases where the 
                            parents claim they have been wrongly separated from 
                            their child have come to light.  In one case in Hampshire, a mother accused of MSBP 
                            was separated from her two seriously ill twins but 
                            allowed to keep her other two children. The twins 
                            were eventually put into care and the mother was forced 
                            to give the other two children up for adoption. She 
                            subsequently emigrated to New Zealand where she alleges 
                            British social services contacted counterparts there 
                            with the result that two other children she had with 
                            another partner ended up being taken into care. Her 
                            case is one of the first that is expected to be appealed 
                            this year.  Janssen Pharmaceutica, makers of cisapride, declined 
                            to comment. |